Novartis AG said profit will rise this year as new medicines help offset competition from copycats of its best-selling drug, ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

which is blocked by the over-the-counter antihistamine drug classes that treat allergy (e.g., chlorcyclizine or fexofenadine) or that limit acid production (e.g., cimetidine or ranitidine).

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...